Shares of Supervalu (NYSE:SVU), owner of Shop `N Save, Save-a-lot and Farm Fresh, have surged more than 230% since the start of the year, as the Eden Prairie, Minn., company benefited from cost-cutting. Stil, expectations for the chain remain low heading into Thursday's earnings report. Revenue is expected to fall more than 51% to $3.88 billion. Earnings per share is expected to drop to 9 cents per share. One reason for the decline is that Supervalu is much smaller than it used to be having unloaded its Acme, Albertsons, Jewel-Osco, Shaw's and Star Markets chains earlier this year.
Kroger (NYSE:KR), the largest supermarket operator, recently reported solid earnings thanks to the growth in its private label brands. Shares of the operator of its namesake stores along with Ralph�� and Fry�� have jumped more than 58% this year. Safeway (NYSE:SWY), which Barron�� recently noted was ��nce a stock market pariah,��has roared back this year, gaining more than 83% this year.
Hot Building Product Stocks To Buy Right Now: Box Ships Inc.(TEU)
Box Ships Inc. owns and operates containerships. As of August 16, 2011, it operated a fleet of 7 containerships with a total carrying capacity of 33,237 twenty-foot equivalent units. The company was founded in 2010 and is based in Athens, Greece.
Advisors' Opinion:- [By ABN]
TAL International Group (TAL) is one of the world's largest lessors of intermodal freight containers for the shipping business with 17 offices in 11 countries and approximately 230 third-party container depot facilities in 40 countries. TAL's fleet consists of approximately 1,238,000 containers and 2,031,000 twenty-foot equivalent units (TEU).
- [By Eric Volkman]
TearLab (NYSE: TEU ) is looking to widen its capital base by more than $32 million in an underwritten public offering of its common stock. The company is floating 2.6 million shares at a price of $13.50 apiece. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 15% of the total number of shares to cover overallotments.
Hot Building Product Stocks To Buy Right Now: Stein Mart Inc.(SMRT)
Stein Mart, Inc. operates retail stores that offer fashion merchandise for women and men in the United States. The company?s stores provide fashion apparel, accessories, shoes, and home fashions. As of April 19, 2011, it operated a chain of 263 retail stores. The company was founded in 1908 and is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By David Trainer]
Unfortunately, FVL's holdings don't look likely to out-perform. 67% of its capital is in stocks with a Dangerous-or-worse rating. Only 12% of its assets are in Attractive-or-better rated stocks. Its holdings include recent Danger Zone picks Rite Aid (RAD), Citigroup (C), and Stein Mart (SMRT). FVL's holdings get their worst scores on valuation.
- [By Reuters]
Joshua Lott/Getty Images NEW YORK -- Several major U.S. retailers posted disappointing sales for November after cautious shoppers pinched their pennies at the start of a shorter holiday season. Some of the companies that reported sales gains ramped up bargains to bring in shoppers who appeared hesitant to splurge. Costco Wholesale (COST) said Thursday that sales at stores open at least a year rose 2 percent, below the 3.3 percent increase analysts were looking for, according to Thomson Reuters. The warehouse club chain said consumer electronics sales fell. Same-store sales at L Brands (LTD), owner of the Victoria's Secret lingerie chain, also came in below expectations. Its drop of 5.5 percent was far deeper than the 1.1 percent decline analysts were projecting. Wall Street analysts are expecting 11 top retailers to report a 2.7 percent increase in same-store sales for November, according to Thomson Reuters. Excluding drugstore operators, which get two-thirds of revenue from prescriptions, that gain is estimated at 2.3 percent. Gap (GPS) will report its November sales after U.S. markets close. Retailers have been contending with low consumer confidence and the need to prod shoppers with bargains this holiday season, which has six fewer days because of a late Thanksgiving. The National Retail Federation on Sunday said U.S. shoppers had spent 2.9 percent less this year over the Thanksgiving weekend, the kickoff to the holiday season. The Conference Board, an industry group, said last week that U.S. consumer confidence fell in November after a sharp drop in October as Americans worried about their future jobs and earnings prospects. Earlier this week, J.C. Penney (JCP) reported a 10.1 percent comparable sales increase, partially reversing a disastrous decline in 2012, but the department store chain had to resort to aggressive bargains. The "environment will remain as competitive" through the holiday season, Chief Executive Officer Myron Ullman said. I
- [By Paul Ausick]
Stein Mart Inc. (NASDAQ: SMRT) reported a 3.8% rise in same-store sales for August, above the 3% estimate from Retail Metrics. In August of last year, sales rose 5.6%.
Top 5 Undervalued Stocks For 2015: Hologic Inc.(HOLX)
Hologic Inc. develops, manufactures, and supplies diagnostic, medical imaging systems, and surgical products for the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment offers breast imaging products, such as Selenia full field digital mammography system, breast tomosynthesis, healthcome mammography products, screen-film mammography systems, SecurView workstation, CAD systems, stereotactic breast biopsy systems, breast biopsy products, breast brachytherapy products, MammoPad breast cushions, and photoconductor coatings, as well as Sentinelle medical MRI breast coils and workstations. This segment also develops a breast imaging platform, Dimensions, which utilizes a tomosynthesis technology to produce 3D images. The Diagnostics segment provides ThinPrep system, a solution for cervical cancer screening; rapid fetal fibronectin test for pre-term birth risk assessment; and hu man papillomavirus offering and InVitro diagnostics for cervical cancer tests. The GYN Surgical segment offers NovaSure system, a minimally-invasive procedure that allows physicians to treat women suffering from excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids; and Adiana system, a form of permanent female contraception intended as an alternative to tubal ligation. The Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and Mini C-Arm imaging systems that are used to perform minimally invasive surgical procedures on a patient?s extremities. Hologic Inc. sells its products through a combination of direct sales and service forces, a network of independent distributors, and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company was founded in 1985 and is headquartered in Bedford, Massachusetts.
Advisors' Opinion:- [By Michael Calia]
Hologic Inc.(HOLX) swung to a fiscal first-quarter loss as revenue weakened, driven by declines in its diagnostics segment, although adjusted earnings and revenue beat expectations.
- [By Ben Levisohn]
Shares of Hologic (HOLX) have plunged today after the maker of medical devices for women reported results that left investors searching for a diagnosis.
The Associated Press has the details:
Hologic said late Monday that it expects lower sales of ThinPrep pap tests, NovaSure endometrial ablations systems, and blood screening tests. Hologic also said sales of its older 2-dimensional Selenia digital mammography system will decline as it begins selling its newer Dimensions systems. The company expects to report adjusted net income of $1.32 to $1.38 per share in its new fiscal year, which started Sept. 29. It forecast $2.43 billion to $2.48 billion in total revenue, down from $2.49 billion in fiscal 2013.
Analysts had predicted much higher net income of $1.63 per share and $2.59 billion in revenue, according to FactSet.
Citigroup’s Amit Bhalla summarizes the good and the bad:
While HOLX beat the Street by $0.02 on the bottom-line, revenues came in light and F2014 guidance was below Street expectations. 3D mammo remains a positive (+50% Y/Y) and GPRO was up +11%, but ThinPrep (-13% Y/Y) and NovaSure weakness remain a headwind. Initial F14 guidance includes revs down -1-3% (Street expected +3%) and during this “transition” year, HOLX expects to complete more asset reviews/sales, further streamline the business, and begin a new $250M share buyback. While we believe these efforts are a positive, a $1.1B write-down on diagnostics (GPRO & ThirdWave) indicates that some businesses may need more time to recover ��we remain Neutral-rated.
Canaccord Genuity’s Jason Mills and team are not pleased. They write:
HOLX�� commentary at fall brokerage meetings portended a flattish outlook for FY14, but actual ��4 guidance on the Q4 call painted an even worse picture of current fundamentals, in our view. While we recognize management is likely attempting to mitigate quarterly misses and suggested FY15 sh
Hot Building Product Stocks To Buy Right Now: BCE Inc. (BCE)
BCE Inc. provides communications solutions to residential, business, and wholesale customers primarily in Canada. The company offers local and long distance telephone services under the Bell Home Phone brand; direct-to-home satellite television (TV) services under the Bell TV name; Internet protocol TV services under the Bell Fibe TV brand; and personal video recorders and online access services. It also provides data services, including Internet access services under the Bell Internet name; Internet protocol based services; and information and communications technology solutions. In addition, the company engages in the rental, sale, and maintenance of business terminal equipment; sale of TV set-top boxes; and provision of network installation and maintenance services for third parties. Further, it offers wireless voice and data communications products and services, such as call display and voicemail, e-mail, Web browsing, social networking, text, picture and video messagi ng, music downloads, ring tunes, ringtones, games and applications, video streaming, live TV, mobile Internet, roaming, and global positioning system navigation services under the Bell and Virgin Mobile brands. Additionally, the company provides media services comprising TV programming services to broadcast distributors. It operates approximately 28 conventional over-the-air stations and 30 English and French-language specialty TV channels; 33 FM and AM radio stations and their related Websites; and Theloop.ca Website. As of December 31, 2012, the company served approximately 2.1 million high-speed Internet access customers through fiber-optic, digital subscriber line, or wireless broadband technology; and 7.7 million wireless customers. BCE Inc. offers its services through call centre representatives, independent dealer stores, and value-added resellers, as well as through its Websites. The company was founded in 1880 and is headquartered in Verdun, Canada.
Advisors' Opinion:- [By Dan Caplinger]
The big news for Madison Square Garden has been the success of its key sports franchises. The New York Knicks basketball team made the playoffs and earned the No. 2 seed in the Eastern Conference. Even more importantly, the long-delayed National Hockey League season finally got going in January, helping resurrect what many had feared would be a lost season, sending shares of MSG, as well as Canadian venue/team-owners Rogers Communications (NYSE: RCI ) and BCE (NYSE: BCE ) , higher. As it turned out, MSG's New York Rangers made the playoffs and will go up against the Washington Capitals in the first round. Playoffs are an especially lucrative time for sports viewership, and usually translate into extra profits for the company's broadcast businesses.
- [By Tom Taulli]
BCE (BCE) is the largest telecom operator in Canada … and sports one whopper of a dividend.
As should be no surprise, the traditional wired voice services segment continues to be weak for BCE, and that’s something we can expect in perpetuity. However, BCE has diversified into other businesses, such as broadband, IPTV, satellite television, radio and mobile, which is helping to smooth its transition.
- [By Eric Lam]
BCE Inc. (BCE) dropped 1.3 percent to a February low, after Macquarie Group Ltd. said that phone shares are vulnerable amid increased regulation. Canadian Pacific Railway Ltd. (CP) lost 4.4 percent to extend losses to a fourth day after its largest shareholder said it will sell part of its stake. WestJet Airlines Ltd. slid 2.3 percent after a measure of customers on its flights declined. A gauge of real estate investment trust fell for a seventh day, the longest streak in three years.
- [By Rich Duprey]
As mobile commerce continues to grow worldwide, Royal Bank of Canada (NYSE: RY ) this week announced its�customers will be able to securely purchase goods and services with debit or credit using smartphones compatible with Bell Canada's (NYSE: BCE ) wireless network as part of a new�mobile payment system the two are launching.
Hot Building Product Stocks To Buy Right Now: Repros Therapeutics Inc.(RPRX)
Repros Therapeutics Inc., a development stage biopharmaceutical company, focused on the development of new drugs to treat hormonal and reproductive system disorders. It is developing Androxal, an oral therapy that normalizes testicular function for the treatment of low testosterone due to secondary hypogonadism. The company is also conducting a phase 2 study of the use of Androxal in the treatment of type 2 diabetes in hypogonadal men. In addition, it is developing Proellex, an orally administered selective blocker of the progesterone receptor in women for the treatment of uterine fibroids and endometriosis; and phentolamine-based product candidate VASOMAX for the treatment of male erectile dysfunction. The company was formerly known as Zonagen, Inc. and changed its name to Repros Therapeutics, Inc. in May 2006. Repros Therapeutics, Inc. was founded in 1987 and is based in The Woodlands, Texas.
Advisors' Opinion:- [By Lisa Levin]
Repros Therapeutics (NASDAQ: RPRX) shares reached a new 52-week high of $26.68 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal庐.
- [By John Udovich]
On Friday, small cap pharma stock Apricus Biosciences Inc (NASDAQ: APRI) jumped just over 10% and not only�did the stock hold onto those gains, it made�another 10% jumps on Monday���meaning its time to take a closer look at the stock along with the performance of other potential benchmarks in the sexual health or reproductive health spaces like The Female Health Company (NASDAQ: FHCO) and Repros Therapeutics Inc (NASDAQ: RPRX).
- [By Jake L'Ecuyer]
Equities Trading UP
Repros Therapeutics (NASDAQ: RPRX) shot up 29.82 percent to $27.60 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal庐. Shares of Kythera Biopharmaceuticals (NASDAQ: KYTH) got a boost, shooting up 26.04 percent to $42.26 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Aeropostale (NYSE: ARO) was also up, gaining 16.75 percent to $10.05 after private equity firm Sycamore Partners reported that it had bought a 7.96 percent stake in the company. - [By Monica Gerson]
Repros Therapeutics (NASDAQ: RPRX) shares climbed 13.42% to $27.05. The volume of Repros Therapeutics shares traded was 319% higher than normal. Repros shares have jumped 54.77% over the past 52 weeks, while the S&P 500 index has gained 16.68% in the same period.
Hot Building Product Stocks To Buy Right Now: Central Garden & Pet Company (CENTA)
Central Garden & Pet Company produces and sells various products for the pet, and lawn and garden supplies markets in the United States. The company operates in two segments, Pet, and Lawn and Garden. The Pet segment supplies products for dogs and cats comprising edible bones, edible and non-edible chews, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and food, cages and habitats, toys, chews, and related accessories for birds, small animals, and specialty pets. It also offers animal and household health, and insect control products; aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources for fish, reptiles, and other aquarium-based pets; and products for horses and livestock. This segment sells its products to independent pet distributors, retail chains, grocery stores, mass merchants, and bookstores under various brand names, which include Ada ms, Aqueon, Avoderm, BioSpot, Farnam, Four Paws, Kaytee, Nylabone, Pinnacle, TFH, Zilla, Altosid, Comfort Zone, Coralife, Interpet, Kent Marine, Oceanic Systems, Pet Select, Pre-Strike, Super Pet, and Zodiac. The Lawn and Garden segment provides grass seeds; wild bird feed, bird feeders, bird houses, and other birding accessories; weed, grass, ant and other herbicide, insecticide, and pesticide products; and decorative outdoor lifestyle and lighting products, such as comprising potteries, trellises and other wood products, and holiday lighting products. This segment sells its products to retail chains, independent garden distributors, grocery stores, nurseries, and garden supply retailers under the AMDRO, GKI/Bethlehem Lighting, Ironite, Pennington, Sevin, Grant�s, Lilly Miller, Matthews Four Seasons, New England Pottery, Norcal Pottery, Over-N-Out, Smart Seed, and The Rebels brand names. The Company was founded in 1955 and is based in Walnut Creek, California.
Advisors' Opinion:- [By Will Ashworth]
At the end of the day, Liquidity Services is a business whose need is an ongoing one. With no debt and lots of cash, I like LQDT’s chances.
Small Caps to Buy #3: Central Garden & Pet (CENTA)In addition to its stock dropping 36% in 2013, Central Garden & Pet (CENTA) has underperformed the S&P 500 by almost 18 percentage points during the past five years while everyone and their dog — small caps, large caps, whatever — has seen impressive gains over that same period.
Hot Building Product Stocks To Buy Right Now: Taseko Mines Limited(TGB)
Taseko Mines Limited engages in the exploration, development, and operation of mineral properties in British Columbia, Canada. The company principally holds interests in the Gibraltar copper-molybdenum mine located north of the City of Williams Lake; the Prosperity gold-copper project situated in the Clinton Mining Division, southwest of the City of Williams Lake; the Harmony gold project located on the Queen Charlotte Islands, also known as Haida Gwaii; and the Aley niobium project situated in the Omineca Mining Division. Taseko Mines Limited was founded in 1966 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Rich Smith]
Vancouver, British Columbia-based Taseko Mines (NYSEMKT: TGB ) needs to find itself a new chief financial officer. The one it had has flown the coop.
Hot Building Product Stocks To Buy Right Now: Primco Management Inc (PMCM)
Primco Management Inc., incorporated on October 14, 2010, is a development-stage company. The Company focuses on offering estate management services for its clients and retention on a range of properties including class A office space, industrial, manufacturing, and warehousing facilities as well as data centers and retail outlets for real estate users. In addition, it also focuses on offering consulting services, including site selection, feasibility studies, exit strategies, market forecasts, strategic planning, and research services. In February 2013, the Company announced that ESMG, Inc. took controlling interest in the Company through the acquisition of more than 80% interest of the Company. In February 2013, it purchased the music catalog of D&B Music. In May 2013, the Company acquired Top Sail Productions.
As of December 31, 2010, the Company did not have any operations. During the year ended December 31, 2010, it did not generate any revenues.
Advisors' Opinion:- [By Peter Graham]
The marijuana field keeps sprouting small cap marijuana stocks like Primco Management Inc (OTCBB: PMCM), Medifirst Solutions Inc (OTCMKTS: MFST) and Modern Mobility Aids, Inc (OTCMKTS: MDRM) which are all trying to seek a high by playing up their connections (no matter how tenuous�� to what many consider to be the next high flying sector. But are these small cap marijuana stocks just blowing smoke at investors? Here is a quick reality check:
Hot Building Product Stocks To Buy Right Now: McCormick & Company Inc (MKC)
McCormick & Company, Incorporated (McCormick) manufactures, markets and distributes spices, seasoning mixes, condiments and other flavorful products to the food industry, retail outlets, food manufacturers and foodservice businesses. The Company�� sales, distribution and production facilities are located in North America and Europe. Additional facilities are based in China, Australia, Mexico, India, Singapore, Central America, Thailand and South Africa. The Company operates in two business segments: consumer and industrial. During the fiscal year ended November 30, 2011, the Company�� consumer business contributed 59% of sales and 79% of operating income and the industrial business contributed 41% of sales and 21% of operating income.
McCormick�� products are sold directly to customers and also through brokers, wholesalers, and distributors. In the consumer segment, products are resold to consumers through a range of retail outlets, including grocery, mass merchandise, warehouse clubs, discount, and drug stores under a range of brands. In the industrial segment, products are used by food and beverage manufacturers as ingredients for their finished goods and by food service customers as ingredients for menu items to enhance the flavor of their foods. Customers for the industrial segment include food manufacturers and the foodservice industry supplied both directly and indirectly through distributors.
Consumer Business
The Company�� brands in the Americas include McCormick, Lawry�� and Club House. The Company also markets brands, such as Zatarain��, Thai Kitchen and Simply Asia. In Europe, the Middle East and Africa (EMEA) its brands include the Ducros, Schwartz and Kamis brands of spices, herbs and seasonings and a line of Vahine brand dessert items. In the Asia/Pacific region its primary brand is McCormick, with the exception of India where its joint venture owns and trades under the Kohinoor brand. The Company�� customers span a variety of retail o! utlets that include grocery, mass merchandise, warehouse clubs, discount and drug stores, served directly and indirectly through distributors or wholesalers. In addition to marketing its products to these customers, the Company is also a supplier of private label items, also known as store brands. More than 250 other brands are sold in the United States with additional brands in international markets.
Industrial Business
In its industrial business, the Company provides a range of products to multinational food manufacturers and foodservice customers. The foodservice customers are supplied both directly and indirectly through distributors. Its range of products include seasoning blends, natural spices and herbs, wet flavors, coating systems and compound flavors. In addition to a broad range of flavor solutions, we strive to achieve customer intimacy.
Advisors' Opinion:- [By Nicholas Ward]
McCormick (MKC) was the clearest buy that I ran across this quarter. I own this stock in my actual portfolio as well as in The Seeking Alpha Experiment. MKC's stock price fell drastically after is 4th quarter earnings release. However, when looking at the numbers I realized that the company set records for revenue, net income, and EPS. These numbers did not meet analyst expectations which is why the stock fell. MKC does support a rather high P/E of 23x and some of this selloff was likely related to profit taking. However, when looking at the long term growth of the company's share price, its prominence within the spice trade, and the fact that MKC (especially in the post dip $60 price range) seemed to be a perfect acquisition candidate, it's lofty P/E did not dissuade me. MKC has given shareholders an annual return of 13% over the past 10 years. McCormick also pays a healthy dividend (1.86% at quarter's end) which it has increased for 27 consecutive years. The company's most recent dividend increase was 10%. MKC's current payout ratio is 42%. This number seems reasonable after MKC's record earnings year. I have no immediate plans for my position in MKC. I believe this stock to be of core holding quality and plan on adding to this position on any significant dips.
- [By Reuters]
Toby Talbot/AP NEW YORK -- A voluntary effort by the world's largest food and beverage companies to remove billions of calories from the products they sell in the United States to help combat the nation's obesity epidemic has far exceeded its five-year goal, according to an independent evaluation released Thursday. In May 2010, 16 of the nation's biggest food and beverage companies, from Coca-Cola (KO) to Kraft Foods Group (KRFT), pledged to remove 1 trillion calories from the U.S. marketplace by 2012 and 1.5 trillion by 2015, compared with a 2007 baseline. In fact, as of 2012 they sold 6.4 trillion fewer calories, found an analysis by researchers at the University of North Carolina at Chapel Hill. "Reports like this, and the fact that they exceeded their commitment by fourfold, really shows that you can make progress in giving American families more healthy options," said Larry Soler, president of the Partnership for a Healthier America, a non-profit chaired by first lady Michelle Obama. The group was formed in 2010 to work with the private sector on anti-obesity strategies. At the time, critics said the Partnership relied too heavily on the good will of the industry and couldn't replace the role of tighter regulation on how food is manufactured and marketed. Such voluntary efforts by industry "are not a magic bullet," said Jeff Levi, executive director of Trust for America's Health, a non-profit policy group. "Particularly with kids, there is a role for regulation" in reducing demand for unhealthy, high-calorie fare. It isn't clear yet how the companies accomplished the dramatic calorie reduction, said UNC public health researcher Barry Popkin, who led the analysis funded by the Robert Wood Johnson Foundation, the nation's largest public health philanthropy. Some of the decline may have come from the recession, as financially strapped families cut back on junk food. When the pledge was announced, companies said they would substitute lower-calorie pro
Hot Building Product Stocks To Buy Right Now: EnteroMedics Inc.(ETRM)
EnteroMedics Inc., a clinical development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity and associated co-morbidities, and other gastrointestinal disorders. The company?s proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. Its product under development is the Maestro System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. The company intends to market its products to potential referral source clinicians, including general practitioners, internists, endocrinologists, and nurses. It has collaboration agreement with Mayo Clinic and Australian Institute of Weight Control. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003 . EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:- [By John Udovich]
Small cap biotech Arena Pharmaceuticals, Inc (NASDAQ: ARNA) soared yesterday and last Friday on earnings as well as news that the company will expand its marketing and supply agreement with Japan based Eisai for its BELVIQ (lorcaserin HCl) obesity drug, meaning it might be time to take a closer look at other biotech stocks like Orexigen Therapeutics, Inc (NASDAQ: OREX), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS) that are in the business of treating obesity. Specifically, Arena Pharmaceuticals announced an expanded agreement providing Eisai with exclusive commercialization rights for all countries worldwide (except for South Korea, Taiwan, Australia, Israel and New Zealand) for BELVIQ where Arena will receive an upfront payment of $60 million and is eligible to receive up to a total of $176.5 million in regulatory and development milestone payments - an increase of $123 million from the amount remaining available under the previous agreement. BELVIQ was approved in June 2012, but didn't reach the market until June 2013 due to logistical concerns like classification by the Drug Enforcement Administration. Its also�approved for use in adults who are obese or who are overweight and who have at least one serious medical condition (e.g. diabetes or high cholesterol).
- [By Jon C. Ogg]
EnteroMedics Inc. (NASDAQ: ETRM) may be a largely unknown microcap stock to most investors. The company is in the development stages of making medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. A new research report has shares rising handily.
- [By John Udovich]
On Tuesday, small cap EnteroMedics Inc (NASDAQ: ETRM) soared 63.5% after reporting new clinical trial data for its Maestro system that is designed to control obesity, meaning it might be time to take a closer look at the stock along with the performance of other small cap obesity drug or treatment players like Arena Pharmaceuticals, Inc (NASDAQ: ARNA), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS).
- [By Roberto Pedone]
One under-$10 health care player that's starting to trend within range of triggering a big breakout trade is EnteroMedics (ETRM), which is engaged in design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities and other gastrointestinal disorders. This stock has been hit hard by the sellers so far in 2013, with shares off sharply by 59%.
If you take a look at the chart for EnteroMedics, you'll notice that this stock recently formed a double bottom chart pattern $1 to $1.01 a share. Following that bottom, shares of ETRM have started to rip higher and trend back above its 50-day moving average at $1.08 a share with strong upside volume flows. This move is quickly pushing ETRM within range of triggering a big near-term breakout trade.
Traders should now look for long-biased trades in ETRM if it manages to break out above some near-term overhead resistances levels at $1.14 to $1.19 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 584,986 shares. If that breakout triggers soon, then ETRM will set up to re-test or possibly take out its next major overhead resistance levels at $1.37 to $1.47 a share. Any high-volume move above those levels will then give ETRM a chance to re-fill some of its previous gap down zone from February that started above $3 a share.
Traders can look to buy ETRM off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $1.08 a share, or below more key near-term support at $1 a share. One can also buy ETRM off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
No comments:
Post a Comment